We have compiled a list of manufacturers, distributors, product information, reference prices, and rankings for Antidiabetic drugs.
ipros is IPROS GMS IPROS One of the largest technical database sites in Japan that collects information on.

Antidiabetic drugs - List of Manufacturers, Suppliers, Companies and Products | IPROS GMS

Antidiabetic drugs Product List

1~5 item / All 5 items

Displayed results

Global Market for Dipeptidyl Peptidase-4 (DPP-4) Inhibitors

Global Market for Dipeptidyl Peptidase-4 (DPP-4) Inhibitors: Nesina, Trajenta, Onglyza, Januvia, Others, Type 2 ...

This research report (Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors M) investigates and analyzes the current status and outlook for the global market of dipeptidyl peptidase-4 (DPP-4) inhibitors over the next five years. It includes information on the overview of the global DPP-4 inhibitors market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include Nesina, Trajenta, Onglyza, Januvia, and others, while the segments by application focus on type 2 diabetes and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size of DPP-4 inhibitors. It also includes the market share of major companies in the DPP-4 inhibitors sector, product and business overviews, and sales performance.

  • Other services
  • Antidiabetic drugs

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Research Material] Global Market for Antidiabetic Drugs

Global Market for Antidiabetic Drugs: Biguanides, Sulfonylureas, Meglitinides, Thiazolidinediones, Dipeptidyl Peptidase IV Inhibitors ...

This research report (Global Anti-Diabetic Drugs Market) investigates and analyzes the current state and outlook for the global market of anti-diabetic drugs over the next five years. It includes information on the overview of the global anti-diabetic drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the anti-diabetic drug market include biguanides, sulfonylureas, meglitinides, thiazolidinediones, dipeptidyl peptidase IV inhibitors, and alpha-glucosidase inhibitors, while the segments by application focus on Type 1 diabetes, Type 2 diabetes, and others. The regional segments calculate the market size of anti-diabetic drugs by dividing it into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in the anti-diabetic drug sector, product and business overviews, and sales performance.

  • Other services
  • Antidiabetic drugs

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Research Material] Global Market for Oral Diabetes Medications

Global Market for Oral Diabetes Medications: Sulfonylureas, Meglitinides, Alpha-Glucosidase Inhibitors, Hospitals, Clinics, Others

This research report (Global Oral Antidiabetic Drugs Market) investigates and analyzes the current status and outlook for the global market of oral diabetes medications over the next five years. It includes information on the overview of the global oral diabetes medication market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the oral diabetes medication market focus on sulfonylureas, meglitinides, and alpha-glucosidase inhibitors, while the segments by application target hospitals, clinics, and others. The regional segments calculate the market size of oral diabetes medications by dividing them into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in oral diabetes medications, product and business overviews, and sales performance.

  • Other services
  • Antidiabetic drugs

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Research Material] Global Market for SGLT2 Inhibitors

World Market for SGLT2 Inhibitors: Dapagliflozin, Canagliflozin, Empagliflozin, Others, Hospital Pharmacies, Retail Pharmacies

This research report (Global SGLT2 Inhibitor Market) investigates and analyzes the current status and outlook for the global SGLT2 inhibitor market over the next five years. It includes information on the overview of the global SGLT2 inhibitor market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include dapagliflozin, canagliflozin, empagliflozin, and others, while the segments by application focus on hospital pharmacies and retail pharmacies. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size of SGLT2 inhibitors. It also includes the market share of major companies in the SGLT2 inhibitor market, product and business overviews, and sales performance.

  • Other services
  • Antidiabetic drugs

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Research Material] The Global Market for Gestational Diabetes Treatment

Global Market for Gestational Diabetes Treatment: Insulin, SGLT-2 Inhibitors, Alpha-Glucosidase Inhibitors, Others, Hospital Pharmacies, Retail Pharmacies, etc.

This research report (Global Gestational Diabetes Treatment Market) investigates and analyzes the current state and future outlook of the global market for gestational diabetes treatment over the next five years. It includes information on the overview of the global gestational diabetes treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the gestational diabetes treatment market include insulin, SGLT-2 inhibitors, alpha-glucosidase inhibitors, and others, while the segments by application focus on hospital pharmacies, retail pharmacies, and online pharmacies. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for gestational diabetes treatment. It also includes the market share of major companies in gestational diabetes treatment, product and business overviews, and sales performance.

  • Other services
  • Antidiabetic drugs

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration